| Englischer Name | Forschungscode | Forschungsphase | Firma | Indikationen | Klinische Studie |
|---|---|---|---|---|---|
| Gebasaxturev | V-937; CVA-21 | Phase 2 Clinical | Viralytics Ltd | Breast Neoplasms; Head and Neck Neoplasms; Melanoma; Neoplasm Metastasis; Prostatic Neoplasms; Urinary Bladder Neoplasms | Details |
| PAT-SC1 | SC-1; PAT-SC1; PAT-SC-1 | Phase 2 Clinical | Oncomab Gmbh | Stomach Neoplasms | Details |
| Recombinant coxsackievirus B3 | Phase 1 Clinical | Wuhan Boweid Biotechnology Co Ltd | Neoplasms | Details |